(Reuters) – Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies Inc, a biopharmaceutical company, Bloomberg News reported on Sunday citing people familiar with the matter.
(Reporting by Angela Christy in Bengaluru; Editing by Sandra Maler)
Comments